Characterization of a human H9N2 influenza virus isolated in Hong Kong

By Saito T.   Lim W.   Suzuki T.   Suzuki Y.   Kida H.   Nishimura S.-I.   Tashiro M.  

Vaccine, Vol. 20, Iss. 1, 2001-10 ,pp. : 125-133

Elsevier

Access to resources Recommend Favorite

ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus

By Rimmelzwaan G.F.   Claas E.C.J.   Van Amerongen G.   de Jong J.C.   Osterhaus A.D.M.E.  

Vaccine, Vol. 17, Iss. 11, 1999-03 ,pp. : 1355-1358

Elsevier

Access to resources Recommend Favorite

Antibody responses and protection against influenza virus infection in different congenic strains of mice immunized intranasally with adjuvant-combined A/Beijing/262/95 (H1N1) virus hemagglutinin or neuraminidase

By Yoshikawa T.   Suzuki Y.   Nomoto A.   Sata T.   Kurata T.   Tamura S.-i.  

Vaccine, Vol. 21, Iss. 1, 2002-11 ,pp. : 60-66

Elsevier

Access to resources Recommend Favorite

Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses

By Treanor J.J.   Kotloff K.   Betts R.F.   Belshe R.   Newman F.   Iacuzio D.   Wittes J.   Bryant M.  

Vaccine, Vol. 18, Iss. 9, 1999-12 ,pp. : 899-906

Elsevier

Access to resources Recommend Favorite

Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human population

By Stephenson I.   Nicholson K.G.   Colegate A.   Podda A.   Wood J.   Ypma E.   Zambon M.  

Vaccine, Vol. 21, Iss. 15, 2003-04 ,pp. : 1687-1693

Elsevier

Access to resources Recommend Favorite